Literature DB >> 27146405

[Sarcoidosis].

B C Frye1, J C Schupp1, T C Köhler1, R E Voll2, J Müller-Quernheim3.   

Abstract

Sarcoidosis is a rare granulomatous disease mainly affecting lymph nodes and the lungs but joints, bones, muscles and other organs can also be affected. Sarcoidosis therefore represents an important differential diagnosis to various rheumatic diseases. For the diagnosis and differential diagnostic clarification, bronchoscopy including endobronchial ultrasound-guided fine needle aspiration of mediastinal and hilar lymph nodes represent the main procedures. Because of the high spontaneous remission rate initiating a therapy requires a therapeutic goal defined by sarcoidosis-associated functional organ impairment, especially for acute sarcoidosis. Cortisone represents the most commonly administered medication whereas methotrexate and azathioprine are well-established second-line medications. Antibodies which neutralize tumor necrosis factors (TNF) are a potential third-line therapy.

Entities:  

Keywords:  Arthritis; Granuloma; Immunosuppression; Lungs; Lymph nodes

Mesh:

Substances:

Year:  2016        PMID: 27146405     DOI: 10.1007/s00393-016-0086-2

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  37 in total

1.  Ultrasound findings in Löfgren's syndrome: is ankle swelling caused by arthritis, tenosynovitis or periarthritis?

Authors:  H Kellner; S Späthling; P Herzer
Journal:  J Rheumatol       Date:  1992-01       Impact factor: 4.666

Review 2.  Corticosteroid therapy in pulmonary sarcoidosis: a systematic review.

Authors:  Shanthi Paramothayan; Paul W Jones
Journal:  JAMA       Date:  2002-03-13       Impact factor: 56.272

3.  Effect and safety of mycophenolate mofetil in chronic pulmonary sarcoidosis: a retrospective study.

Authors:  Anne-Kathrin Brill; Sebastian R Ott; Thomas Geiser
Journal:  Respiration       Date:  2012-12-29       Impact factor: 3.580

Review 4.  Corticosteroids for pulmonary sarcoidosis.

Authors:  N S Paramothayan; T J Lasserson; P W Jones
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

Review 5.  Sarcoidosis: a rheumatologist's perspective.

Authors:  Senol Kobak
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-10       Impact factor: 5.346

Review 6.  Blau syndrome revisited.

Authors:  Carlos D Rose; Tammy M Martin; Carine H Wouters
Journal:  Curr Opin Rheumatol       Date:  2011-09       Impact factor: 5.006

Review 7.  Endobronchial ultrasound-guided transbronchial needle aspiration for diagnosis of sarcoidosis in clinically unselected study populations.

Authors:  Rocco Trisolini; Luigi Lazzari Agli; Carmine Tinelli; Annalisa De Silvestri; Valeria Scotti; Marco Patelli
Journal:  Respirology       Date:  2014-12-05       Impact factor: 6.424

Review 8.  Sarcoidosis.

Authors:  Dominique Valeyre; Antje Prasse; Hilario Nunes; Yurdagul Uzunhan; Pierre-Yves Brillet; Joachim Müller-Quernheim
Journal:  Lancet       Date:  2013-10-01       Impact factor: 79.321

9.  Methotrexate vs azathioprine in second-line therapy of sarcoidosis.

Authors:  Adriane D M Vorselaars; Wim A Wuyts; Veronique M M Vorselaars; Pieter Zanen; Vera H M Deneer; Marcel Veltkamp; Michiel Thomeer; Coline H M van Moorsel; Jan C Grutters
Journal:  Chest       Date:  2013-09       Impact factor: 9.410

Review 10.  Neurological complications of sarcoidosis.

Authors:  Barney J Stern
Journal:  Curr Opin Neurol       Date:  2004-06       Impact factor: 5.710

View more
  2 in total

1.  [Sarcoidosis as a systemic disease].

Authors:  R Bergner; P Korsten
Journal:  Z Rheumatol       Date:  2017-06       Impact factor: 1.372

2.  [26-year-old female with tender red nodules of the left and right tibia as well as hilar lymphadenopathy : Preparation for the medical specialist examination: Part 17].

Authors:  Hannah Poller; Esther von Stebut
Journal:  Hautarzt       Date:  2018-11       Impact factor: 0.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.